Journal article
Oncostatin M Induces Bone Loss and Sensitizes Rat Osteosarcoma to the Antitumor Effect of Midostaurin In vivo
Abstract
PURPOSE: In cultures, the cytokine oncostatin M (OSM) reduces the growth and induces differentiation of osteoblasts and osteosarcoma cells into glial/osteocytic cells. Moreover, OSM sensitizes these cells to apoptosis driven by various death inducers such as the kinase inhibitor staurosporine. Here, we asked whether OSM would have similar effects in vivo.
EXPERIMENTAL DESIGN: Adenoviral gene transfer of OSM (AdOSM) was done in naive and …
Authors
Brounais B; Chipoy C; Mori K; Charrier C; Battaglia S; Pilet P; Richards CD; Heymann D; Rédini F; Blanchard F
Journal
Clinical Cancer Research, Vol. 14, No. 17, pp. 5400–5409
Publisher
American Association for Cancer Research (AACR)
Publication Date
September 1, 2008
DOI
10.1158/1078-0432.ccr-07-4781
ISSN
1078-0432